People behind Swiss Innovation
The Inno-Swiss platform is dedicated to boost
Swiss innovation and the people behind

  • obviz-crm1.JPG
    The team of ObViz

    interax-crm.JPG
    Meet InterAx Biotech

    Meet the latest winners of Venture Kick’ stage two

    Di. 07.07.2015, 14:00

    The ETH and PSI spin-off InterAx Biotech, and the EPFL spin-off ObViz, just won the second stage of Venture Kick and its CHF 20’000 of pre-seed capital. With them, innovative systems for drug discovery and a novel tool to read, exchange and balance opinions on the Internet are on their way to serve a large number of people in the future. ...Read more

    Taking decisions on controversial issues? More obvious with ObViz 
    After winning two great awards in May this year, Lausanne based startup ObViz is now preparing for the big Venture Kick final together with InterAx Biotech from Zurich.

    Controversial topics always have pro and con opinions, especially on the web. People often lack knowledge to exchange, balance or take a decision. The opinion-based and vizualisation platform ObViz helps people in this process, thus exploring and understanding controversies. It addresses the lack of structured information on the internet on controversial subjects using cutting edge artificial intelligence.

    Just as the Press for More Award described on their website: "If you need to make a decision, like vaccinating your child or not, the outcome will be very different depending on what article you happen to read first. Most people don't have an expert that they can just ask, so they need trustworthy information. And that is exactly the role which obviz.com has taken up."

    InterAx Biotech: Helping pharmaceutical companies to develop better drugs
    Over one third of all marketed drugs target G protein-coupled receptors. Dissection of drug-induced signaling requires understanding and access to complexes composed of receptor and signaling protein. These complexes are transient and dynamic in nature. InterAx Biotech, a spin-off of ETH Zurich and Paul Scherrer Institute, provides stabilized complexes for drug discovery. Their products are the missing tools necessary for comprehensive drug-induced signaling analysis contributing to qualified decisions before entering clinical trials.

    Additional Links
    Is your idea good enough? Put it to the test with Venture Kick!
    More about InterAx Biotech
    More about ObViz

  • SiMPLInext.png
    The SIMPLInext team

    TheranOptics.png
    The TheranOptics Team

    Winners of Venture Kick stage 1 revealed

    Do. 18.06.2015, 10:00

    SIMPLInext, TheranOptics, Younergy and Metaco are the fortunate winners of Venture Kick’s first stage. They got kicked with CHF 10’000 of pre-seed capital. Venture Kick will allow them to expand their project and compete for CHF 20'000 next stage. ...Read more

    SIMPLInext markets the next generation of consumable labware for the design of early stage toxicity testing.






    TheranOptics aims to deliver the next generation of smart wound dressings with diagnosis capabilities using its innovative fiber-optic sensor technology.





    Younergy wants to help people manage their own energy. They will provide decentralized energy services anchored in the installation of third party owned solar systems.





    Metaco brings finance to the end-user. It expands Bitcoin with a peer-to-peer trading service and acts as regulated broker to provide a variety of new assets.





    Additional Links
    Is you business idea good enough? Get the kick

  • Xiang-li-venture-crm.jpg
    ZuriMED CEO Xiang Li was in Boston pitching at the Global Pitch Fest with the venture leaders USA when the >>venture>> award ceremony was talking place.

    >>venture>> 2015: venturelab and Venture Kick alumni make it in the TOP 5

    Di. 16.06.2015, 10:30

    Out of 95 business plans and 107 business ideas submitted, the Jury and Advisory Board members of the 2015 >>venture>> competition chose Zurich based startups CUTISS as best business plan and Prognostics as best business idea projects, at the award ceremony held on June 15th in Zurich. Many venturelab and Venture Kick alumni won their winning seat in this year’s competition, in both categories. ...Read more

    1st place - best business plan: CUTISS (UNI Zurich). Deep skin wounds heal badly, developing into debilitating, permanent, disfiguring scars that require intense medical and home care. CUTISS now offers individually customized, minimally scarring skin grafts bio-engineered from a small piece of the patient's skin. The start-up led by Daniela Marino (picture) wins CHF 60'000.

    1st place - best business idea: Pregnostics (ETHZ) is developing a diagnostic tool that measures the cervical stiffness in pregnant women. Monitoring cervical stiffness allows identifying women at risk of preterm birth, thus solving the problem of preterm birth risk assessment in pregnancy.

    Pregnostics is an alumnus of venturelab' Startup Essentials - Acceleration Workshops in 2015.

    2nd-5th place business plan

    2nd: Zurimed (ETHZ) Knee ligament injuries are among the most common and severe musculoskeletal traumas. ZuriMED is an innovative team specialized in orthopedic biomechanics and biomaterials that has developed a disruptive technology with potential to revolutionize anterior cruciate ligament reconstruction. Zurimed receives CHF30'000.

    ZuriMED’s CEO, Xiang Li, is a venture leader USA 2015. He was in Boston during the >>venture>> award ceremony, pitching against American entrepreneurs at the Global Pitchfest with the 19 other members of the Swiss national startup team. ZuriMED is also getting ready for the big Venture Kick final which will take place in August this year (fingers crossed!).

    3rd: Inositec (ETHZ) is a drug development project at the preclinical proof-of-concept stage with a small molecule for the treatment of Clostridium difficile infection, a bacterial infection of the colon that has become the most common health- care-associated infection.

    Alike ZuriMED this year, Matthias Ivarsson, Inositec CEO, was part of the Swiss national startup team in 2014. Inositec is also a Venture Kick alumus.

    4th: Gamaya (EPFL) provides an integrated solution for large-scale monitoring and diagnostics of crops for precision agriculture. Gamaya acquires imaging data using sensors mounted on drones, and translates the data into actionable in- formation for farmers, such as optimum rates of application for fertilisers and crop protection chemicals, as well as early alerts for disease, pests and weeds. Gamaya is a Venture Kick alumnus.

    5th: The microGauge project (ETHZ) aims at developping and commercializing next generation pressure sensors for industrial vacuum coating systems. The proposed high-precision, full-range sensor offers means to replace up to four state-of- the-art sensors with one single compact gauge. 

    2nd-5th place business idea 

    2nd: TapTools (ETHZ)
    , a device developed for non-destructive testing. TapTools believes that their product will be the next key technology in quality control testing. The novel technology goes beyond visual inspection and ensures comprehensive material characterization in a hundredth of a second.

    Clara Beck, TapTools CEO, took part in venturelab’ Startup Essentials - Acceleration Workshops in 2015.

    3rd: Sun bioscience (EPFL) is a biotech company that provides next generation cell culture platforms. The startup specializes on making three-dimensional organotypic cultures faster, more efficient and more reproducible in order to develop better and new drugs and to define their efficacy in a patient-specific manner. Sun Bioscience is a venturelab alumnus (venture challenge courses).

    4th: Sensetag (ETHZ) developed a class of patent-pending, smart, inex- pensive, ultrasmall DNA-based tracers able to measure a range of properties (temperature, oxidative stress, light, pH) in challenging commercial, industrial, research or clinical settings (e.g. deep underground, within live cells). Sensetag is a venturelab alumnus (venture challenge courses).

    5th: FireHUD (EPFL) helps firemen to see through smoke and darkness by showing a thermal image overlay on an augmented reality mask. This increases their situational awareness and capacity to search for victims, therefore making their work safer and more efficient.

    FireHUD is an alumnus of venturelab’ Startup Essentials - Acceleration Workshops in 2015.

  • emile2.jpg
    Emile de Rijk is the CEO of SWISSto12, an EPFL spin-off created in 2011.

    «In the evolution of SWISSto12, the main difficulty has been to identify the right market»

    Mo. 15.06.2015, 08:30

    Emile de Rijk is the CEO of SWISSto12, a spin-off from EPFL created in 2011. First active in the field of scientific equipment, the startup focuses since 2014 on the market of antennas for satellite telecommunications, which promise is to equip our planet with broadband Internet access. SWISSto12 manufactures its antennas thanks to a 3D printing process in plastic material before they are metalized on the basis of a patented process (Metal Coated 3D printed Plastic Antennas). The recent contract that SWISSto12 signed with the European Space Agency (ESA) enables it to foresee a market worth more than a billion dollars. The startup’s expertise is among others based on an EPFL PhD thesis. The young company could also count on the support of startup programs, such as Venture Kick and venturelab, since its beginning....Read more

    Hats off for your contract with ESA: how did it all start?
    Last year, we applied to a program of the EPFL Swiss Space Center, which collaborates with ESA. Our application file retained the attention of ESA experts, who invited us to meet them. We discussed a lot about the potential of our 3D printed antennas for satellite telecommunications. Today, we are the only ones to possess this manufacturing technology in the domain of antennas. The initial conversation led to a concrete project.

    What is the potential of your technology for ESA?
    Current satellite antennas, entirely crafted in metal, are complicated to assemble and rather expensive due to their weight. Today, 1 kilo of “antenna” costs a few tens of thousands francs to launch into space, and a telecommunication satellite contains a few hundreds kilos of components. Our 3D printed plastic antennas allow a reduction of weight by a factor 10. They are manufactured in one piece, so no assembling is required. ESA believes in the commercial potential of our technology, and this is why they support it. Their goal is to one day use our technology for ambitious space missions, such as the launch of the space probe Rosetta in 2004.

    What are the perspectives of such a project, for SWISSto12?
    This project allows us to establish our credibility in the space domain. Our antennas can also be used on ground, which allows us to sight the market of movement connectivity, enabling plane, trains, boat and vehicles to stay connected to the Internet. We will also be able to reinforce our engineering team in a near future.

    «Our potential clients are called Airbus, Boeing, Space X or Thales Alenia Space»

    You started in 2010 – tell me about the evolution of SWISSto12 until today and your vision for the future.
    When we started in 2011, we were focused on the development of terahertz components for the market of scientific instruments (medical imagery, quality control of electronic chips, magnetic resonance, etc.) Despite its technological advancement, this market is still a niche market. This acknowledgement led us to take an ambitious turn towards the domain of telecommunications, in 2014.

    In the evolution of SWISSto12, the main difficulty was to identify the right market. Our technology was promising since the start, but we were not aware of its exact commercial potential. Despite an increasing economical basis in the first domain of activity, which we will keep in the future, we decided to enter a market which was in line with our ambitions.

    In the long run, our objective is to become an actor of reference in the domain of antennas for satellite telecommunications, in space and on ground. Our potential clients are called Airbus, Boeing, Space X or Thales Alenia Space. We are currently seeking Serie A fundings from European corporate VCs active in space industry and aeronautics. These funds will help us mark the first milestones toward our growth objectives, to work on the aeronautical certification of our products and to open a sales office in the US, where most of our market is present.

    An EPFL PhD thesis is at the basis of SWISSto12, which you successfully finished in 2013. Other than the help of EPFL and numerous prizes and rewards, you also benefited from the help of the Venture Kick and venturelab programs to become an accomplished entrepreneur...
    We received precious and numerous awards. Switzerland is full of supporting mechanisms for young companies, such as Venture Kick, venturelab, deVigier, FIT, >>venture>>, CTI - without mentioning the help of EPFL.

    Venture Kick helped us to «come out of the lab» thanks to pre-seed capital of CHF 130’000. Moreover, the structure of the process in 3 steps allowed us to think our project through and to become the feedback of confirmed experts.

    In 2012, we had the great opportunity to be part of the Swiss national startup team in Boston thanks to the acceleration program for world-class startups, venturelab. This enabled us to enlarge our network in Switzerland and abroad, and to improve our skills for the acquisition of clients and investors. In 2012, we entered the TOP100 Swiss Startups ranking which enabled us to reinforce our credibility.

    All this contributed to our impulse, together with amazing internal competences. Although the entrepreneurial adventure is hard, I would start the adventure exactly the same way if it was to be repeated.

    Additional Links
    Learn more about SWISSto12
    Discover the Swiss national startup team of 2015
    venturelab: World class startups. Swiss made.
    Is your idea good enough? Put it to the test with Venture Kick
    Read the EPFL article about the project (15.06.2015)

  • CashS1.JPG
    Sylvain Bertolus, CashSentinel CEO, and Olivier L., CashSentinel client from Bern

    CashSentinel closes a round of seed funding with BAS, GoBeyond and selected angel investors, while crossing the milestone of 1 million CHF processed through its service

    Fr. 12.06.2015, 12:00

    CashSentinel is a Swiss Fintech that developed an innovative financial service to facilitate and secure financial transactions, currently dedicated to the commerce of vehicles. The service is offered on the marketplace AutoScout24 since January 2015....Read more

    “Thanks to our partnership with AutoScout since the beginning of the year, we’re seeing a steady increase of transactions through our service. We’re delighted to notice that our client satisfaction ratings are consistently very high, often to the point that they would not consider any other alternative after having experienced CashSentinel” says Sylvain Bertolus, CEO of the company. “Today we’re very pleased to announce having crossed the CHF 1 million processed milestone, which illustrates the quality of our service and its growing acceptance. And yet this is only really the beginning, as the market holds massive potential for growth since more than 500’000 vehicles change hands every year, in Switzerland alone.”

    Go Beyond Investing's CEO, Brigitte Baumann, stated that Go Beyond provided seed capital because, “we saw an investment in CashSentinel as being in line with our investors’ interest in FinTech and were impressed with the value of CashSentinel’s concept. Its present partnerships as well as those in the pipeline are first class, and offer tremendous potential for growth.”

    BAS, the association Business Angels Switzerland also supported this innovative FinTech because of its realistic business plan and its very focused strategy, contrasting with the lack of differentiation of many initiatives in the payment world today.

    Mr Olivier L. (picture) used CashSentinel in May to purchase an Audi A5, found on AutoScout24. CashSentinel marked the occasion with a gift of appreciation to Mr L., whose transaction took CashSentinel over the 1 million CHF milestone. “Easy, fast and secure. CashSentinel really solved the issue we were experiencing in synchronizing the payment and delivery of the car with my seller”, says the client.

    Martial Mathieu, Head of Marketing at CashSentinel, adds “Our growing success in Switzerland is cornerstone to our European development: Customers from France, UK and other European countries have an even higher need for safe payments than Swiss clients.”

    About CashSentinel
    CashSentinel won the Venture Kick final in 2013, the Swisscom StartUp Challenge 2014 and the TOP100 Startup Award 2014. CashSentinel is the first Swiss online payment service built to bring high security and confidence when buying and selling a used vehicle, without manipulating cash.

  • biowatch-crm1.jpg
    The team of BioWatch

    medicaltemplates-crm1.jpg
    The team of Medical Templates

    Discover the venture case winners: A new way in mobile payment protection and a cost-effective solution for needle guidance

    Do. 11.06.2015, 10:00

    BioWatch, the latest venture leader US and Medical Templates are the winners of venture kick’s second stage. They obtained CHF 20’000 of pre-seed capital and are qualified for the next stage to win, if they are successful, CHF 100’000 more....Read more

    The BioWatch is the next step in mobile payment protection and smart device interaction. The startup develops a wearable biometric technology as an alternative solution to current authentication methods (PIN, passwords, cards, keys, fingerprint, face) based on vein recognition. 

    Medical Templates’ mission is to simplify the life of neuro radiologists and their patients. Their first product is a device to reduce intervention time of the CT guided puncture process, effectively making the treatment more comfortable for patients and reducing their received radiation dose. Thereby also intervention costs are reduced and new double oblique puncture channels become readily available.

    Learn more about the the CEO of BioWatch Matthias Vanoni, who is in the next two weeks in the US with the Swiss national startup team:

    Additional Links
    Is you business idea good enough? Get the kick
    Learn more about the Swiss national startup team

  • MH.png
    The Swiss entrepreneur and philanthropist Martin Haefner

    Martin Haefner supports young companies emerging from Swiss universities and institutions of higher learning

    Mi. 10.06.2015, 14:00

    The Swiss entrepreneur and philanthropist Martin Haefner will support Venture Kick for the next five years, significantly contributing to the development of high potential business ideas emerging from Switzerland’s best institutions of higher learning. ...Read more

    For Martin Haefner, supporting Venture Kick is an investment that yields great return for the future of Switzerland: «Getting seed capital is often a hurdle for many innovative, dynamic and aspiring startups. Venture capital from the private sector is the key to overcoming it. As a member of a materially privileged class I'm happy to support in this way as many high potential business ideas as possible, which bring our country forward».

    In 2005, Martin Haefner took over the chairmanship of the family-owned Careal Holding AG from his father and AMAG founder Walter Haefner. Since 2003 he holds the chairmanship of AMAG Automobil- und Motoren AG. Prior to that, as a member of the board of directors, he worked - after his studies in mathematics at ETH Zurich - as a mathematics teacher at the cantonal baccalaureate schools in Baden and Lucerne from 1981 to 2005.

    Initial startup financing: The key to success
    Pascale Vonmont, Delegate of Venture Kick' strategic committee and Deputy Director of Gebert Rüf Stiftung, is welcoming Martin Haefner's commitment: “The access to a national network of experts, entrepreneurs and investors enables those who hold innovative projects to reinforce the commercial quality of their idea, since the start. The quality of the supported projects, such as Abionic, Climeworks, Composyt Light Labs or InSphero, together with the commitment of outstanding entrepreneurs such as André Hoffmann, Hansjörg Wyss and from now on, Martin Haefner, shows the strength of the Venture Kick approach".

    Venture Kick: A strong demand
    Beat Schillig and Jordi Montserrat, responsible for the operational management of the Venture Kick initiative, are very happy about the positive development of the program, launched in 2007: “The interest of Swiss academy members (i.e. students, postgraduates, researchers and professors) has strongly increased. In 2014, 30 startups applied  each month to the program, which is 50% more compared to the year before. Today, only four projects can be financed every month. The support from Martin Haefner will enable more talented Swiss scientists to embrace the entrepreneurial path”.

    Additional Links
    More information about Venture Kick

  • PolyneuronPharmaceuticals_RubenHerrendorf©TinaSturzenegger_ifj1.jpg
    Ruben Herrendorff of Polyneuron Pharmaceuticals ©Tina Sturzenegger

    CellSpring_ChrisMillan©TinaSturzenegger_ifj1.jpg
    Chris Millan of CellSpring ©Tina Sturzenegger

    A new era in treatments of autoimmune diseases and clinical trials: Two spin-offs kicked by CHF 130.000 each

    Di. 02.06.2015, 14:00

    Two great biotech startups, Polyneuron Pharmaceuticals from University of Basel and CellSpring from ETH Zurich, raised CHF 130.000 each by winning the third and last round of Venture Kick. Both spin-offs are starting a new era in treatments of autoimmune diseases and clinical trials. ...Read more

    When a person is affected by an infection, the body creates specialized immune cellsand antibodies that attack foreign infectious agents. In the case of autoimmune diseases such as multiple sclerosis, rheumatoid arthritis or Crohn's disease, there is an abnormal response of the body’s immune system towards self-tissues. This involves an overproduction of pathogenic auto-antibodies causing inflammation and tissue destruction. Current immunosuppressive drugs unselectively suppress the immune system, frequently leading to serious therapy side effects that are an intolerable burden to many patients.  

    Urgent medical need for effective and safe therapies
    The University of Basel spin-off Polyneuron Pharmaceuticals is developing a groundbreaking drug class for the treatment of autoimmune disorders. Their technology platform “Antibody-Catch®” enables the design of drugs that selectively inactivate disease-causing autoantibodies, while leaving the immune system intact. This pioneering therapeutic approach holds great potential for effective and safe treatments for antibody-mediated autoimmune diseases. “Polyneuron strives to make Antibody-Catch® a clinical reality and hopes to make a difference of people’s lives suffering from autoimmune diseases. With Venture Kick our startup can take an important step towards the realization of improved treatments for autoimmune diseases”, says CEO Dr. Ruben Herrendorff.

    The next level in 3D cell culture
    Bringing a new drug to market costs between 1-2 billion CHF and takes over a decade to complete. For the last half-century, pharma companies and academic labs have relied on 2-dimensional cell structures to test potential new medicines. That is changing rapidly now as researchers observe more and more that cells grown in 3D structures mimic human organs and tumors much more closely. The two founders of CellSpring, Dr. Chris Millan and Kramer Schmidt, have devised a faster, more cost-effective method for developing 3D cell structures than current products to test medication. The innovation enables more reliable and earlier ”stop/go” decision making in the drug development timeline. CellSpring’s vision is to reduce the number of drugs that fail during clinical testing and to reduce the number of animals needed for preclinical drug screening. But CTO Dr. Chris Millan knows that great innovation is not enough: “We are talking about bringing change to the highly standardized and regulated drug development process. Our 3D cell culture models will need to be rigorously validated before they are widely accepted in the industry. That’s our focus now and with the great support of Venture Kick we are up for the challenge!”

    Polyneuron Pharmaceutical and CellSpring are members of the Swiss national startup team 2015, the venture leaders, and will travel to Boston and New York on June 9th for a 10 days entrepreneurial business development trip: Watch the presentation video of Ruben Herrendorff and Chris Millan here:

    Presentation video of Chris Millan:



    Presentation video of Ruben Herrendorff:

    Additional Links
    More about Polyneuron Pharmaceutical
    More about CellSpring
    Is you business idea good enough? Get the kick

  • Nicolas29011.jpg
    Nicolas Durand (picture) and co-founder Iwan Märki met at EPFL during their PhD studies.

    Abionic starts the commercialization of its revolutionary diagnostic platfrom

    Mi. 27.05.2015, 10:00

    On May 22, 2015, the ambassador of Swiss nano-, bio- and medical- technology know-how Abionic announced the launch of its allergy test on the market as well as the incorporation of its US subsidiary in Boston....Read more

    Switzerland's 3rd best startup Abionic is the first company in the world to sell a quantitative system for rapid allergy tests. After raising CHF 3.8 million in 2014 to further develop its catalog of allergy-specific reagents, the EPFL spin-off, 2010 Venture Kick winner and venture leader USA, just launched its first product on the market, called the abioSCOPE. The system developed by Abionic consists of a round disk the size of a CD that holds up to eight small, transparent capsules and a reading device into which the disk is inserted. The capsules contain nano-chambers, where specific proteins present in drops of blood from the patient are quantified within minutes. The reading unit is equipped with a touch screen that is used to operate the device and which shows the results. In addition, an iPad app allows the doctor to do other tasks, such as quickly print out a report.  

    "We succeeded in bringing a new technology to a real certified product on the market"

    “Starting commercialization is one of the most important step for a start-up company: It means that we succeeded in bringing a new technology to a real certified product on the market. We are definitively entering an exciting phase!” The first sales have been realized in Switzerland. Abionic plans to start European sales at the next EAACI Congress (European Academy of Allergy and Clinical Immunology) which will take place in June. In addition to the launch the company announced the incorporation of its US subsidiary in Boston, MA, that will support its internationalization strategy.

    Discover the abioSCOPE developed by Abionic in video:



    A great success for Sitzerland's 3rd best startup

    For the second consecutive year in 2014, Abionic was elected 3rd best Swiss startup in the TOP100 ranking. Its co-founders, Nicolas Durand and Iwan Märki, met at EPFL during their PhD studies and benefited from the support of Venture Kick since the company’s early days: «Venture Kick helped us to gain a global vision of our activities and not loose ourselves into details. I would recommend the program to anyone who is interested to enter the Swiss startups ecosystem”, concludes Durand.

    Abionic was also part of the Swiss national startup team in 2010, "one of the best moments in my entrepreneurial career", said Nicolas Durand in our interview of 2014 (in French).

    Additional Links
    Like Abionic, become a venture leader in the USA - or China
    Kick-start your startup with Venture Kick
    Learn more about Abionic (Article in the 2014 Venture Kick annual report issued in January 2015)
    Read our interview of Abionic when they raised CHF 3.8 million in October 2014

  • obviz.JPG
    Claudiu Musat from Obviz is going to pitch his project on the second stage of Venture Kick soon.

    Two great awards for Venture Kick alumnus Obviz

    Do. 21.05.2015, 16:00

    On May 3, 2015, Venture Kick alumnus Obviz won a prestigious European award for better journalism, the Press for More Award. A week later, the EPFL spin-off won the 20th SICTIC Investor Day in Lausanne. ...Read more

    The Press for More award

    ‘Difference Day’ - which took place on May 3 in Brussels - aims at putting forward the freedom of speech and of the press as part of our fundamental democratic rights. The event is organized by the Brussels Platform for Journalism together with BOZAR, the Evens Foundation and iMinds, under the patronage of UNESCO.

    The award recognizes a European project that contributes to better journalism through the use of technological innovation. The winning project typically stimulates participation, has a strong impact and significant growth potential.

    A total of 29 impressive projects from 15 European countries had been submitted for the award. Nevertheless, the jury members unanimously voted for one specific project to receive the ‘Press for More’ award 2015 on May 3. The winner –  OBVIZ.com (When it’s not obvious, it’s ObViz) – helps people explore and understand controversies. It addresses the lack of structured information on the internet on controversial subjects using cutting edge artificial intelligence. If you need to make a decision, like vaccinating your child or not, the outcome will be very different depending on what article you happen to read first. Most people don't have an expert that they can just ask, so they need trustworthy information. And that is exactly the role OBVIZ.com has taken up.

    SICTIC Investor Day
    Organized for the 5th time in Lausanne by web entrepreneur Sébastien Flury (www.startupolic.com) and Swiss ICT Investor Club (www.sictic.ch), SICTIC Investor Day Lausanne gathered more than 60 people at Debiopharm Headquarters.

    8 startups from Western Switzerland were selected, among 22 applications, proving once again that internet startup scene in Switzerland is lively. After a presentation of the recently created Swiss ICT Investor Club and Innovation Forum Lausanne, it was time for the 90-seconds pitches. For a change in tech events, there were more women than men among startup presenters: 5 women entrepreneurs pitched the audience! The audience selected SThar (predictive analytics), Xsensio (biochemical wearable devices), Obviz (user engagement) and Tawipay (international money transfers) for the 7 minutes pitches. Xsensio is also a Venture Kick alumnus.

    After four highly qualitative pitches, EPFL-based startup and Venture Kick alumnus ObViz was picked as winner of the competition by the jury. Claudiu Musat received a Samsung Galaxy tablet, offered by Innovaud. ObViz helps readers explore and understand controversies and intends to increase user retention and engagement for media producers. A beta version of ObViz is up and running.

    Claudiu Musat invited everyone to use and test the platform, to help him and his team improve the tool. The next SICTIC Investor Day Lausanne will take place on 26th of October 2015 at CVCI. Investors can already secure their seat on http://sicticlausanne.eventbrite.com  

    Additional Links
    Kick-start your startup with Venture Kick

Angezeigt: 1 bis 10 von 187 1 2 3 4 5 6

Watch videos from success stories

TOP 100 Startups

Powered by startup.ch and Handelszeitung

60 venture kickers made it to the TOP 100 startups

Each year, startup.ch launches the TOP 100 STARTUP AWARD in cooperation with the Handelszeitung. From over 100,000 young companies, the 100 most innovative and promising Swiss startups are picked by top startup experts.

Check out the TOP 100

venture leaders

venture leaders program – ten intense days in USA or China

Swiss startups ready to take over the World.

The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.

More

venture kick

Kick your startup idea to success with venture kick

venture kick helps potential entrepreneurs by giving them the opportunity to win up to CHF 130,000. Moreover, startups can also use the know-how of experienced experts and entrepreneurs and be granted access to a national network of investors.

Apply

venturelab workshops

Powered by industry professionals

Learn from entrepreneurs and industry leaders

In the last 10 years venturelab alumni have raised several 100 millions from investors and built successful businesses. Now they are ready to share with the next generation of talented hightech startups.

Learn more about the program

Directory of active investors

Powered by startup.ch

The investors in early stage Swiss startups

In the last 5 years the venture kick startups raised more than 365 millions. Following all these transactions we compiled and update the list of active startup investors in different fields and stages.

Filter your potential investors

Institut für Jungunternehmen

The first address for Startups in Switzerland

More than 50.000 startups were accompanied by the IFJ. A little more then 25 years ago, we have made it our mission to guide these entrepreneurs on their way to successful businesses. So they can develop their role as a part of the Swiss economy.

More

Connecting the dots between Switzlerand and the world

Gioia Vichis Deutscher is the director of swissnex Brazil. After spending four years as the Haed of Startup and Innovation Services for swissnex San Francisco, Gioia Deutscher is now taking the lead in opening a new swissnex office in Brazil.

More on Swissnex Brazil

Suzanne Hraba-Renevey is the director of swissnex Singapore. Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoree. Ut wisi enim ad minim veniam, quis nostrud exerci tation.

More on Swissnex Singapore

Pascal Marmier is the director of swissnex China. Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoree. Ut wisi enim ad minim veniam, quis nostrud exerci tation.

More on Swissnex China

Felix Moesner is the director of swissnex Boston. Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoree. Ut wisi enim ad minim veniam, quis nostrud exerci tation.

More on Swissnex Boston

Chistian Simm is the director of swissnex San Francisco. Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoree. Ut wisi enim ad minim veniam, quis nostrud exerci tation.

More on Swissnex San Francisco

Balz Strasser is the director of swissnex India. Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoree. Ut wisi enim ad minim veniam, quis nostrud exerci tation.

More on Swissnex India

  • 60 venture kickers made it to the TOP 100 startups

    Each year, startup.ch launches the TOP 100 STARTUP AWARD in cooperation with the Handelszeitung. From over 100,000 young companies, the 100 most innovative and promising Swiss startups are picked by top startup experts.

    Check out the TOP 100
  • Kick your startup idea to success with venture kick

    venture kick helps potential entrepreneurs by giving them the opportunity to win up to CHF 130,000. Moreover, startups can use the know-how of experienced experts and entrepreneurs and be granted access to a network of investors.

    More
  • Swiss startups ready to take over the World.

    The venture leaders have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.

    More
  • The first address for Startups in Switzerland

    More than 50.000 startups were accompanied by the IFJ. A little more then 25 years ago, we have made it our mission to guide these entrepreneurs on their way to successful businesses. So they can develop their role as a part of the Swiss economy.

    More